Skip to content

HHRI News & Press Releases

HHRI News & Press Releases

People who experience homelessness face earlier and greater risk of death, report finds

January 26, 2023

Death rate among those experiencing homelessness is triple that of general population Governor’s historic housing stability package invests in solutions to support Minnesotans experiencing homelessness across the housing spectrum People who experience homelessness in Minnesota die at much higher rates than the general population, according to a new report produced…

Read More

HHRI investigators highlighted by CTSI as UMN Mothers Leading Science

January 26, 2023

Hennepin Healthcare Research Institute (HHRI) investigators Anne Frosch, MD, MPH, and Sandra Japuntich, PhD, LP, were featured in the University of Minnesota’s Clinical & Translational Science Institute (CTSI) news welcoming the fourth cohort of researcher-moms into Mothers Leading Science, a yearlong career development program for research-intensive faculty in the health sciences…

Read More

Hennepin Healthcare asking for community input on local trauma research study for blood clotting agent

January 20, 2023

Excessive bleeding (bleeding out) is the most common cause of preventable death after someone experiences an injury. Researchers at Hennepin Healthcare are asking for the community’s input on whether they should participate in an international study to see if a blood clotting drug – given soon after arrival in the…

Read More
access to healthcare

Incarceration of parent is associated with worse access to health care for millions of U.S. children, new study shows

November 15, 2022

According to a new study, children exposed to parental incarceration had worse access to primary care and more unmet dental and mental health care needs than their peers, even after accounting for income, insurance status, rurality, and other important factors. With the United States having the highest incarceration rate in…

Read More

Focus on global health outcomes shouldn’t exclude jails and prisons

June 21, 2022

Minneapolis, Minn. – The state of healthcare access and quality in jails and prisons should not be excluded from international efforts to understand and improve healthcare coverage for vulnerable populations, according to a recent publication in The Lancet Public Health authored by Tyler Winkelman, MD, MSc, Division Chief of General…

Read More
Quit Smoking

Hennepin Healthcare investigators study game to help people quit smoking

May 27, 2022

Minneapolis, Minn. – Hennepin Healthcare Research Institute is testing an innovative way to help people quit smoking – by letting them bet on themselves and win real money. It’s part of a new game called QuitBet and it’s being funded by a National Institutes of Health (NIH) research grant administered…

Read More

Dr. Warren McKinney appointed Hennepin Healthcare Research Institute VP for Equity in Research

March 10, 2022

Hennepin Healthcare Research Institute (HHRI) is proud to announce that Warren McKinney, PhD, has been named HHRI’s VP for Equity in Research. In this role, Dr. McKinney joins the HHRI Board of Directors and the institute’s executive leadership team. The VP for Equity in Research is a new position at…

Read More

Statewide research program to address impact of racism on cardiovascular health inequities

October 19, 2021

People in Minnesota’s Black, Indigenous and communities of color experience some of the worst health disparities in the United States. A new research center, the Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM), led by the University of Minnesota (U of M) and Mayo Clinic, will research the impact…

Read More

Medication Access for Opioid Use Disorder Lower Among Those Involved with Criminal Justice System

April 5, 2021

Medicaid Expansion Helped Increase Access to Medications for Opioid Use Disorder, but Limitations Exist to Broadening Access. Approximately 6.5 million people are under correctional supervision in the United States on any given day. Justice-involved individuals (people currently or recently in prison or jail, on probation or parole, or arrested) experience…

Read More

Dr. Johansen Receives NKF J. Michael Lazarus Award for Dedication to Kidney Health

March 24, 2021

Each year the National Kidney Foundation (NKF) considers the work of hundreds of specialists in the field of nephrology and selects among them those who most exemplify the relentless efforts of NKF to enhance the lives of patients through action, education, and accelerating change. NKF presents this award each year to…

Read More

What a Kidney Transplant Means for You or a Loved One

March 7, 2021

HHRI investigators Warren McKinney, PhD, and Ajay Israni, MD, MS, were guests on the African American Leadership Forum’s (AALF) Black Leadership Re-Defined radio show and podcast series on KMOJ (89.9FM) radio on March 7.  They joined host Sylvia Bartley, PhD, to discuss the intricacies of kidney transplantation as well as…

Read More

Walz, Flanagan Announce Groundbreaking Partnership Between State of Minnesota, Health Care Systems on Race and Ethnicity Data Collection

March 5, 2021

— State announces additional, targeted strategies to promote equity in vaccination — The Walz-Flanagan Administration announced publication of vaccination data by race and ethnicity made possible through the groundbreaking partnership between the State of Minnesota and the Minnesota Electronic Health Record (EHR) Consortium. This unique and innovative collaboration between public…

Read More

Dr. Bart talks about meth addiction and treatment on Healthy Matters on WCCO radio

January 25, 2021

Hennepin Healthcare physician and HHRI investigator Dr. Gavin Bart was Dr. David Hilden’s guest Healthy Matters on WCCO 830-AM radio on Sunday, January 24, talking about meth addiction and treatment. Methamphetamine use is increasing across the country and in Minnesota has surpassed opioid use as a leading cause (behind only…

Read More

Breaking Through the Wall of Stigma in Healthcare

January 22, 2021

Stigma is a huge barrier for people with opioid use disorder and is particularly problematic in healthcare.  In a series of NIH videos, Gavin Bart, MD, PhD, talks about the stigma in healthcare around substance use disorders, barriers to treatment, and empowering people and humanizing addiction.   Read more about…

Read More

HHRI Awarded Continuation of SRTR Contract

September 21, 2020

Minneapolis, Minn. – The Chronic Disease Research Group (CDRG) of the Hennepin Healthcare Research Institute (HHRI) has renewed its federal contract to operate the Scientific Registry of Transplant Recipients (SRTR). Among its key functions, the SRTR evaluates the status of the nation’s solid organ transplant system and provides analytic support to…

Read More

Hennepin Healthcare takes a pulse of the pandemic

September 10, 2020

by hennepinmedical — COVID-19’s rapid arrival in Minnesota in March 2020 created myriad changes across the community – and a snapshot of that impact is now available in a report from Hennepin Healthcare. A collaboration for quality improvement between Hennepin Healthcare and Hennepin Healthcare Research Institute (HHRI) emerged to design…

Read More

New website offers added decision support for kidney and liver transplant candidates searching for a transplant center

August 5, 2020

Minneapolis, Minn. – Transplant candidates face obstacles in finding a transplant program that transplants patients like them. A new online tool developed by researchers at Hennepin Healthcare Research Institute (HHRI) and the University of Minnesota (UMN) is helping to remove those barriers. The website transplantcentersearch.org allows patients to conduct searches…

Read More

Hennepin Healthcare collaborates with Mayo Clinic on convalescent plasma protocol as a therapeutic treatment for COVID-19 patients

June 25, 2020

Minneapolis, Minn. – Hennepin Healthcare Research Institute (HHRI) is collaborating with the Mayo Clinic to engage in a clinical protocol using convalescent plasma as a therapeutic treatment for COVID-19 patients. Convalescent plasma has appeared to be of benefit for the treatment of certain infectious diseases, including infections from respiratory viruses.…

Read More

Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan

April 20, 2020

Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…

Read More

Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19

April 9, 2020

Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.  Hennepin Healthcare is a clinical site…

Read More
input search string and hit enter